Skip to main content

NIH $ frozen amid conflict probe

An Emory University psychiatrist under investigation by a Senate committee for allegedly failing to disclose more than a million dollars in pharmaceutical company pay has stepped down as principal investigator on a $9.3 million National Institutes of Health research grant. The researcher, Charles Nemeroff, is the linkurl:second;https://www.the-scientist.com/blog/display/54935/ scientist who has recently stepped down from an NIH grant amid Senate scrutiny of undisclosed conflicts of interest. Ac

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
An Emory University psychiatrist under investigation by a Senate committee for allegedly failing to disclose more than a million dollars in pharmaceutical company pay has stepped down as principal investigator on a $9.3 million National Institutes of Health research grant. The researcher, Charles Nemeroff, is the linkurl:second;https://www.the-scientist.com/blog/display/54935/ scientist who has recently stepped down from an NIH grant amid Senate scrutiny of undisclosed conflicts of interest. According to Ron Sauder, an Emory spokesperson interviewed by the linkurl:__Atlanta Journal-Constitution__,;https://www.ajc.com/metro/content/metro/dekalb/stories/2008/10/14/nemeroff_emory_funds.html the NIH will withhold the remainder of funding on the five-year grant - which began in July 2006 - "pending resolution of outstanding issues relating to conflict of interest procedures." Nemeroff linkurl:resigned;https://www.the-scientist.com/blog/display/55072/ his chairmanship of Emory's psychiatry department on October 3 as the university launched its own investigation into his apparent failure to disclose industry ties. The NIH is now requiring the university's Office of Sponsored Programs (OSP) and all Emory researchers hoping to secure agency funding to submit and assure detailed records of who is participating on proposed projects and what financial conflicts they may have. "As you may know, the University has been under scrutiny in connection with our business practices for the management of research financial conflict of interest," Emory's vice president for research administration David Wynes wrote in a linkurl:memo;https://www.pharmalot.com/wp-content/uploads/2008/10/emory-coi-1a.jpg to university researchers last week. "It is important to note that, in the future, OSP will non [sic] submit any NIH grant application until disclosures have been received for every Investigator participating in the study." In the memo, Wynes explained that "as of October 8, 2008 the NIH has imposed special award conditions on all awards made to Emory University. The special award conditions will affect both the submission of proposals to the NIH as well as the receipt of funding." (Thanks to the linkurl:__Pharmalot__;https://www.pharmalot.com/2008/10/nih-requires-emory-to-disclose-all-conflicts/ blog for posting a copy of the memo.) Nemeroff was originally accused of linkurl:failing to report payments from drug maker GlaxoSmithKline;https://www.the-scientist.com/blog/display/55072/ by Senate Finance Committee ranking Republican Charles Grassley, who has recently linkurl:investigated;https://www.the-scientist.com/blog/display/55058/ similar apparent indiscretions among other NIH-funded researchers.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays